Cita APA

Miller, K. D., O’Neill, A., Perez, E. A., Seidman, A. D., & Sledge, G. W. (2012). A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: A trial coordinated by the Eastern Cooperative Oncology Group. Oxford University Press.

Chicago Style Citation

Miller, K. D., A. O’Neill, E. A. Perez, A. D. Seidman, i G. W. Sledge. A Phase II Pilot Trial Incorporating Bevacizumab Into Dose-dense Doxorubicin and Cyclophosphamide Followed By Paclitaxel in Patients With Lymph Node Positive Breast Cancer: A Trial Coordinated By the Eastern Cooperative Oncology Group. Oxford University Press, 2012.

Cita MLA

Miller, K. D., et al. A Phase II Pilot Trial Incorporating Bevacizumab Into Dose-dense Doxorubicin and Cyclophosphamide Followed By Paclitaxel in Patients With Lymph Node Positive Breast Cancer: A Trial Coordinated By the Eastern Cooperative Oncology Group. Oxford University Press, 2012.